Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Discovery of novel, potent, selective and orally bioavailable HPK1 inhibitor for enhancing the efficacy of anti-PD-L1 antibody

作者:Shenxin Zeng, Mingfei Wu, Yuyuan Jin, Yingqiao Ye, Heye Xia, Xinyi Chen, Jinxin Che, Jinxin Che, Zunyuan Wang, Ying Wu, Xiaowu Dong, Yinqiao Chen, Wenhai Huang · 发表于:European Journal of Medicinal Chemistry · 年份:2024 · DOI:10.1016/j.ejmech.2024.116206 · 被引用次数:19 · 研究领域:Melanoma and MAPK Pathways、Peptidase Inhibition and Analysis、Colorectal Cancer Treatments and Studies